Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea

Blood

Volumn 89, Issue 7, 1997, Pages 2554-2559

  Styles, Lori A ^a   Lubin, Bertram ^b   Vichinsky, Elliott ^b   Lawrence, Sandy ^b   Hua, Mandy ^b   Test, Samuel ^b   Kuypers, Frans ^b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD36 ANTIGEN; CELL RECEPTOR; HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL OCCLUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE ADHESIVENESS; FEMALE; HUMAN; HUMAN CELL; MALE; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOCYTE; SICKLE CELL ANEMIA;

EID: 0030895689     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2554     Document Type: Article

References (36)

1. Eaton WA, Hofrichter J: Sickle cell hemoglobin polymerization. Adv Protein Chem 40:263, 1990
2. 1-integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82:189, 1993
3. 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 82:3548, 1993
4. Brittain HA, Eckman IR, Wick TM: Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 120:538, 1992
5. Vordermeier S, Singh S, Biggerstaff J, Harrison P, Grech H, Pearson TC, Dumonde DC, Brown KA: Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumour necrosis factor (TNF). Br J Haematol 81:591, 1992
6. Kasschau MR, Barabino GA, Bridges KR, Golan DE: Adhesion of sickle neutrophils and erythrocytes to fibronectin. Blood 87:771, 1996
7. Kaul DK, Nagel RL: Sickle cell vaso-occlusion: Many issues and some answers. Experientia 49:5, 1993
8. Hebbel RP: Beyond hemoglobin polymerization: The red blood cell membrane and sickle disease pathophysiology. Blood 77:214, 1991
9. Hebbel RP, Marc MD, Boogaerts B, Eaton JW, Steinberg MH: Erythrocyte adherence to endothelium in sickle cell anemia: A possible determinant of disease severity. N Engl J Med 302:992, 1980
10. Kaul DK, Fabry ME, Nagel RL: Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci USA 86:3356, 1989
11. Gee BE, Platt OS: Sickle reticulocytes adhere to VCAM-1. Blood 85:268, 1995
12. Fabry ME, Fine E, Rajanayagam V, Factor SM, Gore J, Sylla M, Nagel R: Demonstration of endothelial adhesion of sickle cell in vivo: A distinct role for deformable sickle cell discocytes. Blood 79:1602, 1992
13. Smyth SS, Joneckis CC, Parise LV: Regulation of vascular integrins. Blood 81:2827, 1993
14. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
15. Jacobsen K, Kravitz J, Kincade PW, Osmond DG: Adhesion receptors on bone marrow stromal cells: In vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and y-irradiated mice. Blood 87:73, 1996
16. Hamamura K, Matsuda H, Takeuchi Y, Habu S, Yagita H, Okumura K: A critical role of VLA-4 in erythropoiesis in vivo. Blood 87:2513, 1996
17. Yanai N, Sekine C, Yagita H, Obinata M: Roles for integrin very late activation antigen-4 in stroma-dependent erythropoiesis. Blood 83:2844, 1994
18. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Endothelial cell interactions with sickle cell, sickle train, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152, 1987
19. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068, 1994
20. Conforti G, Dominguez-Jimenez C, Zanetti A, Gimbrone MA, Cremona O, Marchisio PC, Dejana E: Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood 80:437, 1992
21. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA: Membrane glycoprotein CD36: A review of its role in adherence, signal transduction, and transfusion medicine. Blood 80:1105, 1992
22. Okumura N, Tsuji K, Nakahata T: Changes in cell surface antigen expressions during proliferation and differentiation of human erythroid progenitors. Blood 80:642, 1992
23. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM: Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vasoocclusion. Blood 81:2137, 1993
24. Browne PV, Mosher DF, Steinberg MH, Hebbel RP: Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am J Hematol 51:296, 1996
25. Sugihara K, Sugihara T, Mohandas N, Hebbel RP: Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood 80:2634, 1992
26. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, and the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317, 1995
27. Charache S, Dover GJ, Moore MD, Eckert S, Ballas SK, Koshy M, Milner PFA, Orringer EP, Phillips G, Platt OS, Thomas GH: Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:2555, 1992
28. Platt O, Thorington MS, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR: Pain in sickle cell disease: Rates and risk factors. N Engl J Med 325:11, 1991
29. Orringer EP, Blythe DSB, Johnson AE, Phillips G Jr, Dover GJ, Parker JC: Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia. Blood 78:212, 1991
30. Ballas SK, Dover GJ, Charache S: Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo. Am J Hematol 32:104, 1989
31. Singer K, Chernoff AI, Singer L: Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation. Blood 6:413, 1951
32. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 65:154, 1980
33. Smolinski PA, Eckman JR, Wick TM: Increased tenacity of sickle erythrocyte-endothelial cell adherence by involvement of multiple receptor-ligand interactions. Blood 86:298a, 1995 (abstr, suppl 1)
34. Smolinski PA, Offermann MK, Eckman JR, Wick TM: Double-stranded RNA induces sickle erythrocyte adherence to endothelium: A potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia. Blood 85:2945, 1995
35. Ballas SK, Marcolina MJ, and the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia: In vivo RBC survival and ferrokinetic data in patients with sickle cell anemia before and after treatment with hydroxyurea. Blood 86:140a, 1995 (abstr, suppl 1)
36. Hillery CA, Walls EN, Du MC, Scott JP: Hydroxyurea therapy decreases red blood cell adhesion to thrombospondin and laminin in hemoglobin SS disease Blood 86:250a, 1995 (suppl)